...
首页> 外文期刊>Frontiers in Veterinary Science >Pharmacokinetics of Free Oxytetracycline and Oxytetracycline Loaded Cockle Shell Calcium Carbonate-Based Nanoparticle in BALB/c Mice
【24h】

Pharmacokinetics of Free Oxytetracycline and Oxytetracycline Loaded Cockle Shell Calcium Carbonate-Based Nanoparticle in BALB/c Mice

机译:BALB / C小鼠中游离氧基杂环素和催产素加载的碳酸钙壳钙碳酸钙的药代动力学

获取原文
           

摘要

The development and utilization of nano-antibiotics is currently gaining attention as a possible solution to antibiotic resistance. The aim of this study was therefore to determine the pharmacokinetics of free oxytetracycline (OTC) and oxytetracycline loaded cockle shell calcium carbonate-based nanoparticle (OTC-CNP) after a single dose of intraperitoneal (IP) administration in BALB/c mice. A total of 100 female BALB/c mice divided into two group of equal number (n = 50) were administered with 10 mg/kg OTC and OTC-CNP, respectively. Blood samples were collected before and post administration from both groups at time 0, 5, 10, 15, 30 minutes and 1, 2, 6, 24 and 48 hrs, and OTC plasma concentration was quantified using validated HPLC-UV method. The pharmacokinetic parameters were analysed using a non-compartment model. The Cmax values of OTC in OTC-CNP and free OTC treated group were 64.99 μg/ml and 23.53 μg/ml, respectively. OTC was detected up to 24 hr in OTC-CNP group as against 1hr in free OTC group following intraperitoneal administration. In OTC-CNP group, the plasma elimination rate of OTC was slower while half-life, area under the curve and volume of distribution were increased. In conclusion, the pharmacokinetic profile of OTC in OTC-CNP group differ significantly from free OTC. However, further studies are necessary to determine the antibacterial efficacy of OTC-CNP for treatment of bacterial diseases.
机译:纳米抗生素的开发和利用目前正在关注抗生素抗性的可能溶液。因此,该研究的目的是在BALB / C小鼠中单剂量腹膜内(IP)给药后,确定游离催产素(OTC)和催产素的药代动力学和催化素加载的沟槽碳酸钙壳碳酸盐基纳米粒子(OTC-CNP)。将总共​​100个雌性BALB / C小鼠分成两组相等数(n = 50),分别用10mg / kg OTC和OTC-CNP施用。之前收集血液样品,并在0,5,10,15,30分钟和1,2,6,24和48小时的两个基团中施用,并且使用验证的HPLC-UV方法定量OTC等离子体浓度。使用非室内模型分析药代动力学参数。 OTC-CNP和游离OTC处理基团中OTC的CMAX值分别为64.99μg/ mL和23.53μg/ ml。在腹膜内给药后,在OTC-CNP组中检测到OTC-CNP组中的24小时,在游离OTC组中进行1小时。在OTC-CNP组中,OTC的等离子体消除速率在半衰期较慢,曲线下的面积和分布体积增加。总之,OTC-CNP组OTC的药代动力学谱与自由OTC显着不同。然而,进一步的研究是确定OTC-CNP治疗细菌疾病的抗菌效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号